The Effect of Escape Room Game on Reproductive Health Knowledge and Gender Equality Perception

March 26, 2026 updated by: GÜL BÜŞRA ALTUNAY DAVRAN, Karamanoğlu Mehmetbey University

The Effect of Escape Room Game-Supported Reproductive Health Education on University Students' Knowledge Level of Sexual and Reproductive Health and Gender Perception: A Randomised Controlled Trial

This study aims to evaluate the impact of an "escape room" educational game on university students' knowledge of sexual/reproductive health and their perceptions of gender equality. The research compares a group of students who received traditional theoretical education with a group that participated in an escape room game titled "Hidden Files in the Secret Laboratory" in addition to the same theoretical training. The primary goal is to determine if gamified learning enhances knowledge levels and shapes gender equality perceptions more effectively than standard education alone.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This is a pretest-posttest, parallel-group, randomized controlled experimental study conducted at Karamanoğlu Mehmetbey University (2024-2025 Spring Semester).

The study population consists of 80 volunteer students enrolled in the Reproductive Health and Family Planning course, divided into two groups:

Intervention Group (n=40): Received standard theoretical education plus the "Hidden Files in the Secret Laboratory" themed escape room game.

Control Group (n=40): Received only the standard theoretical education.

Data collection was performed using a Descriptive Information Form, the Sexual Health and Reproductive Health Knowledge Scale, and the Gender Perception Scale. The study follows the CONSORT 2025 guidelines. Statistical analysis is performed using SPSS 26.0, including Chi-Square, ANOVA, and t-tests to compare pretest and posttest results between the groups.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
80

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being 18 years of age or older.
  • Being proficient in the Turkish language.
  • Enrolled in the "Reproductive Health and Family Planning" course for the first time.

Exclusion Criteria:

  • Having any impairment that prevents effective communication (e.g., being a foreign national with insufficient Turkish reading/writing skills, or having hearing, speech, or cognitive disorders).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention Group
Both groups receive a standard theoretical education on reproductive health and family planning. Immediately following the educational session, the intervention group participates in the "Hidden Files in the Secret Laboratory" themed escape room game as an additional active learning module.
Behavioral: Escape Room Game on Reproductive Health and Gender Equality
A gamified educational intervention using an escape room format to teach reproductive health, sexual rights, and gender equality. Participants solve puzzles and complete tasks related to these topics within a set timeframe to improve their knowledge and perceptions.
Behavioral: Standard Theoretical Education
Standard theoretical education on reproductive health and family planning.
Active Comparator: Control Group
This group receives the same standard theoretical education on reproductive health and family planning as the intervention group. To ensure educational equality and prepare all students equally for their final examinations, no additional game intervention is applied during the study period. However, to maintain ethical fairness, students in the control group are allowed to play the escape room game upon request after the post-test data collection is completed.
Behavioral: Standard Theoretical Education
Standard theoretical education on reproductive health and family planning.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Gender Perception Scale Score
Time Frame: Baseline (Pre-test) and 1 week after the intervention (Post-test).
This scale evaluates the participants' perceptions of gender equality. It consists of multiple items rated on a Likert-type scale. Total scores are calculated, where higher scores reflect a more positive and egalitarian perception of gender roles.
Baseline (Pre-test) and 1 week after the intervention (Post-test).
Sexual Health and Reproductive Health Knowledge Scale Score
Time Frame: Baseline (Pre-test) and 1 week after the intervention (Post-test).
This scale measures the participants' knowledge levels regarding sexual and reproductive health. The score is calculated based on correct answers to specific questions. Higher scores indicate a higher level of knowledge.
Baseline (Pre-test) and 1 week after the intervention (Post-test).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Karamanoğlu Mehmetbey University

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Necmettin Erbakan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 10, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 15, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 15, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 8, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 8, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 16, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 1, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 26, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • E-36321956-300-230705
  • 25DR9001 (Other Grant/Funding Number: Necmettin Erbakan University)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared with other researchers to ensure the confidentiality and privacy of the student participants, as per the ethical approval and informed consent obtained for this study.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings